JIB-04
產(chǎn)品名稱:JIB-04
產(chǎn)品描述:
| 產(chǎn)品描述 | JIB-04 is a pan-selective Jumonji histone demethylase inhibitor. |
| 靶點(diǎn)活性 | JARID1A:230 nM, JMJD2B:435 nM, JMJD2E:340 nM, JMJD2D:290 nM, JMJD2A:445 nM |
| 體外活性 | 在H358和A549小鼠異種移植模型中,JIB-04抑制Jumonji組蛋白脫甲基酶的活性,抑制腫瘤細(xì)胞生長(zhǎng). |
| 體內(nèi)活性 | 在肺癌和前列腺癌細(xì)胞系中(IC50=10 nM),JIB-04下調(diào)增殖基因,阻斷細(xì)胞生長(zhǎng)。 |
| 細(xì)胞實(shí)驗(yàn) | For cell viability assays, cells are plated at 1500-3000 cells/well in 96 well plates and treated the next day with increasing doses of compound over 4 days and their viability assessed by standard MTS assays using Promega’s Cell Titer or Cell Titer-Glo reagents according to the manufacturer’s protocols. Absorbance at 490 nm and 650 nm or luminescence is measured by a Spectra Max or a FlouroStar Omega plate reader. Data are normalized to the untreated controls (100% viability). Each cell line is tested in 2-5 independent assays, each containing 4-8 replicates. IC50 values are calculated using DIVISA, a high-throughput software, developed in hous, for storing and analyzing drug sensitivity assays. Dose-response curves are plotted using a non-linear regression model and IC50s are determined from the fitted curves. The average IC50 derived from 2-5 independent assays, each containing 4-8 replicates is reported. (Only for Reference) |
| 別名 | NSC 693627, 5-氯-2(1H)-吡啶酮 (2E)-(苯基-2-吡啶基亞甲基)腙, JIB 04 |
| 分子量 | 308.76 |
| 分子式 | C17H13ClN4 |
| CAS No. | 199596-05-9 |
存儲(chǔ)
Powder: -20°C for 3 years | In solvent: -80°C for 2 years
溶解度
DMSO: 30.9 mg/mL (100 mM)
( < 1 mg/mL refers to the product slightly soluble or insoluble )
聯(lián)系我們:
郵箱:2519696869@qq.com
QQ: 2519696869
電話:18066853083
微信:18066853083
公司介紹:
西安齊岳生物科技有限公司是集化學(xué)科研和定制與一體的高科技化學(xué)公司。業(yè)務(wù)范圍包括化學(xué)試劑和產(chǎn)品的研發(fā)、生產(chǎn)、銷(xiāo)售等。涉及產(chǎn)品為通用試劑的分銷(xiāo)、非通用試劑的定制與研發(fā),涵蓋生物科技、化學(xué)品、中間體和化工材料等領(lǐng)域。
主營(yíng)產(chǎn)品:COF、MOF單體系列:三蝶烯衍生物、金剛烷衍生物、四苯甲烷衍生物、peg、上轉(zhuǎn)換、石墨烯、光電材料、點(diǎn)擊化學(xué)、凝集素、載玻片、蛋白質(zhì)交聯(lián)劑、脂質(zhì)體、蛋白、多肽、氨基酸、糖化學(xué)等。


